As the U.S. and other Western nations withdraw funding for independent media and democratic institutions in places like ...

Benedict Peters does not trade in noise. He builds—quietly, consistently, powerfully. He builds bridges between nations, ...

Could Trump secure a third term with a scenario in which he's elected Speaker of the House and a stooge GOP ticket promises ...

Ben Coleman is an award-winning freelance writer based in Portland, Oregon. For more than a decade his work has appeared in ...

Pliant Therapeutics' stock plummeted, but Kevin Tang’s stake raises takeover hopes. Find out why PLRX stock’s cash reserves ...

While Pliant Therapeutics and Acelyrin recently blocked ever-eager acquirer Concentra Biosciences with “poison pill” defenses ...

To find the best banana bread recipe on the internet, we tested four popular recipes that use different ingredients and ...

He’s facing pushback, but working to sweep it away. A pliant Congress has largely forsaken its oversight role since Trump thundered back into office, leaving the courts as the main impediment to his ...

Pliant Therapeutics, Inc.’s PLRX share price has dipped by 10.89%, which has investors questioning if this is right time to ...

That rustic dough, made with spelt, rye, and soft winter wheat, offers a pliant, earthy canvas for the wide variety of flatbread specialties he makes at Majdal, from myriad opened-faced safeha ...

NEW YORK, March 23, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Pliant Therapeutics, Inc. (“Pliant” or the ...